Keratoconjunctivitis Sicca
Showing 1 - 25 of 57
Dry Eye, Keratoconjunctivitis Sicca Trial in Edison, Woodland Park (Nasal Guide)
Recruiting
- Dry Eye
- Keratoconjunctivitis Sicca
- Nasal Guide
-
Edison, New Jersey
- +1 more
Jun 26, 2023
Dry Eye, Keratoconjunctivitis Sicca, Ocular Inflammation Trial in Mexico City (punctum plug insertion, Eye Drops, Lubricant)
Recruiting
- Dry Eye
- +2 more
- punctum plug insertion
- Eye Drops, Lubricant
-
Mexico City, Coyoacán, MexicoAsociación para Evitar la Ceguera en México (APEC)
Nov 9, 2022
Keratoconjunctivitis Sicca, Dry Eye Disease Trial in Cleveland (OTX-101 0.05%, OTX-101 0.09%, Vehicle)
Completed
- Keratoconjunctivitis Sicca
- Dry Eye Disease
- OTX-101 0.05%
- +2 more
-
Cleveland, Ohio(unnamed)
Aug 26, 2022
Keratoconus, Ocular Surface Disease, Pellucid Marginal Corneal Degeneration Trial in Needham (Ocular surface optical coherence
Completed
- Keratoconus
- +8 more
- Ocular surface optical coherence tomography
-
Needham, MassachusettsBostonSight
Mar 24, 2022
Sjogren's Syndrome, Keratoconjunctivitis Sicca Trial in Nashville (Levocarnitine, Placebo)
Recruiting
- Sjogren's Syndrome
- Keratoconjunctivitis Sicca
- Levocarnitine
- Placebo
-
Nashville, TennesseeVanderbilt University Medical Center
Jan 31, 2022
Differential Diagnosis of Sjögren's Versus Non-Sjögren's Dry Eye
Recruiting
- Keratoconjunctivitis Sicca
- +3 more
- Questionnaires
- +2 more
-
Baltimore, MarylandWilmer Eye Insitute, Johns Hopkins School of Medicine
Jan 18, 2022
Dry Eye Syndrome, Keratoconjunctivitis Sicca Trial in United States (0.05% Voclosporin Ophthalmic Solution (VOS), 0.10% VOS,
Completed
- Dry Eye Syndrome
- Keratoconjunctivitis Sicca
- 0.05% Voclosporin Ophthalmic Solution (VOS)
- +3 more
-
Newport Beach, California
- +8 more
Dec 8, 2021
Keratoconjunctivitis Sicca Trial in Rancho Cordova, Edgewood, New York (cyclosporine, vehicle of OTX-101)
Completed
- Keratoconjunctivitis Sicca
- cyclosporine
- vehicle of OTX-101
-
Rancho Cordova, California
- +2 more
Nov 18, 2021
Keratoconjunctivitis Sicca, Dry Eye Trial in United States (tavilermide ophthalmic solution, Placebo)
Completed
- Keratoconjunctivitis Sicca
- Dry Eye
- tavilermide ophthalmic solution
- Placebo
-
Phoenix, Arizona
- +21 more
Oct 18, 2021
Dry Eye, Dry Eye Syndromes, Keratoconjunctivitis Sicca Trial (Intranasal Neurostimulator)
Completed
- Dry Eye
- +2 more
- Intranasal Neurostimulator
- (no location specified)
Sep 22, 2021
Keratoconjunctivitis Sicca, Dry Eye Disease Trial in United States (Lifitegrast, Placebo)
Completed
- Keratoconjunctivitis Sicca
- Dry Eye Disease
- Lifitegrast
- Placebo
-
Waterbury, Connecticut
- +12 more
Jun 2, 2021
Dry Eye Syndrome, Keratoconjunctivitis Sicca Trial in Taipei City (Pro-ocular™ Topical Gel, Placebo Topical Gel)
Enrolling by invitation
- Dry Eye Syndrome
- Keratoconjunctivitis Sicca
- Pro-ocular™ Topical Gel
- Placebo Topical Gel
-
Taipei City, TaiwanTri-Service General Hospital, National Defense Medical Center
May 12, 2021
Dry Eye Syndromes, Keratoconjunctivitis Sicca Trial in United States (KPI-121 0.25% Ophthalmic Suspension, Vehicle of KPI-121
Completed
- Dry Eye Syndromes
- Keratoconjunctivitis Sicca
- KPI-121 0.25% Ophthalmic Suspension
- Vehicle of KPI-121 0.25% Ophthalmic Suspension
-
Phoenix, Arizona
- +59 more
Jan 19, 2021
Dry Eye Syndromes, Keratoconjunctivitis Sicca Trial in United States (KPI-121, Placebo)
Completed
- Dry Eye Syndromes
- Keratoconjunctivitis Sicca
- KPI-121
- Placebo
-
Artesia, California
- +10 more
Jan 4, 2021
Dry Eye Syndromes, Keratoconjunctivitis Sicca Trial in United States (KPI-121 0.25% Ophthalmic Suspension, Vehicle of KPI-121
Completed
- Dry Eye Syndromes
- Keratoconjunctivitis Sicca
- KPI-121 0.25% Ophthalmic Suspension
- Vehicle of KPI-121 0.25% Ophthalmic Suspension
-
Birmingham, Alabama
- +61 more
Dec 10, 2020
Keratoconjunctivitis Sicca Trial in Andover (Low Dose 0.155µg/mL SkQ1 ophthalmic solution, High Dose 1.55µg/mL SkQ1 ophthalmic
Completed
- Keratoconjunctivitis Sicca
- Low Dose 0.155µg/mL SkQ1 ophthalmic solution
- +2 more
-
Andover, MassachusettsLawrence General Hospital
Oct 12, 2020
Keratoconjunctivitis Sicca Trial in East Hanover (Pimecrolimus, Vehicle)
Completed
- Keratoconjunctivitis Sicca
-
East Hanover, New JerseyNovartis
May 22, 2020
Keratoconjunctivitis Sicca, Dry Eye Syndrome Trial in Houston (Dexamethasone, Artificial tear)
Completed
- Keratoconjunctivitis Sicca
- Dry Eye Syndrome
- Dexamethasone
- Artificial tear
-
Houston, TexasBaylor College of Medicine, Alkek Eye Center
Jan 22, 2020
Keratoconjunctivitis Sicca Trial in Irvine (Lotemax, Restasis, Soothe® Lubricant Eye Drops)
Completed
- Keratoconjunctivitis Sicca
- Lotemax
- +2 more
-
Irvine, CaliforniaBausch & Lomb Incorporated
Aug 28, 2019
Keratoconjunctivitis Sicca Trial in Torrance (1% Tavilermide Ophthalmic Solution, Placebo Ophthalmic Solution)
Completed
- Keratoconjunctivitis Sicca
- 1% Tavilermide Ophthalmic Solution
- Placebo Ophthalmic Solution
-
Torrance, CaliforniaMIM-726 Investigational Site
Aug 13, 2019
Keratoconjunctivitis Sicca Trial in Louisville, Nashville (1% Tavilermide Ophthalmic Solution, Placebo Ophthalmic Solution)
Completed
- Keratoconjunctivitis Sicca
- 1% Tavilermide Ophthalmic Solution
- Placebo Ophthalmic Solution
-
Louisville, Kentucky
- +1 more
Aug 13, 2019
Dry Eye Syndromes, Keratoconjunctivitis Sicca, Lacrimal Apparatus Diseases Trial in Columbus (Systane Complete, Systane Ultra)
Completed
- Dry Eye Syndromes
- +7 more
- Systane Complete
- Systane Ultra
-
Columbus, OhioThe Ohio State University College of Optometry
May 22, 2019
Dry Eye Syndrome, Keratoconjunctivitis Sicca Trial in Waterbury, Norfolk (Oculeve Intranasal, Sham, Oculeve Extranasal)
Completed
- Dry Eye Syndrome
- Keratoconjunctivitis Sicca
- Oculeve Intranasal
- +2 more
-
Waterbury, Connecticut
- +1 more
Apr 4, 2019